دورية أكاديمية
أعرض في EDS

Stereo-EEG-guided network modulation for psychiatric disorders: Interactive holographic planning.

التفاصيل البيبلوغرافية
العنوان: Stereo-EEG-guided network modulation for psychiatric disorders: Interactive holographic planning.
المؤلفون: Noecker AM; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Department of Biomedical Engineering, Duke University, Durham, NC, USA., Mlakar J; Interactive Commons, Case Western Reserve University, Cleveland, OH, USA., Bijanki KR; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA., Griswold MA; Interactive Commons, Case Western Reserve University, Cleveland, OH, USA; Department of Radiology, Case Western Reserve University, Cleveland, OH, USA., Pouratian N; Department of Neurosurgery, University of Texas Southwestern, Dallas, TX, USA., Sheth SA; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA., McIntyre CC; Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA; Department of Biomedical Engineering, Duke University, Durham, NC, USA; Department of Neurosurgery, Duke University, Durham, NC, USA. Electronic address: cameron.mcintyre@duke.edu.
المصدر: Brain stimulation [Brain Stimul] 2023 Nov-Dec; Vol. 16 (6), pp. 1799-1805. Date of Electronic Publication: 2023 Dec 20.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101465726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4754 (Electronic) Linking ISSN: 18764754 NLM ISO Abbreviation: Brain Stimul Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York : Elsevier
مواضيع طبية MeSH: Deep Brain Stimulation*/methods , Mental Disorders*/therapy, Humans ; Prospective Studies ; Brain/diagnostic imaging ; Electroencephalography
مستخلص: Background: Connectomic modeling studies are expanding understanding of the brain networks that are modulated by deep brain stimulation (DBS) therapies. However, explicit integration of these modeling results into prospective neurosurgical planning is only beginning to evolve. One challenge of employing connectomic models in patient-specific surgical planning is the inherent 3D nature of the results, which can make clinically useful data integration and visualization difficult.
Methods: We developed a holographic stereotactic neurosurgery research tool (HoloSNS) that integrates patient-specific brain models into a group-based visualization environment for interactive surgical planning using connectomic hypotheses. HoloSNS currently runs on the HoloLens 2 platform and it enables remote networking between headsets. This allowed us to perform surgical planning group meetings with study co-investigators distributed across the country.
Results: We used HoloSNS to plan stereo-EEG and DBS electrode placements for each patient participating in a clinical trial (NCT03437928) that is targeting both the subcallosal cingulate and ventral capsule for the treatment of depression. Each patient model consisted of multiple components of scientific data and anatomical reconstructions of the head and brain (both patient-specific and atlas-based), which far exceed the data integration capabilities of traditional neurosurgical planning workstations. This allowed us to prospectively discuss and evaluate the positioning of the electrodes based on novel connectomic hypotheses.
Conclusions: The 3D nature of the surgical procedure, brain imaging data, and connectomic modeling results all highlighted the utility of employing holographic visualization to support the design of unique clinical experiments to explore brain network modulation with DBS.
Competing Interests: Declaration of competing interest CCM is a paid consultant for Boston Scientific Neuromodulation, receives royalties from Hologram Consultants, Neuros Medical, Ceraxis, Qr8 Health, and is a shareholder in the following companies: Hologram Consultants, Surgical Information Sciences, BrainDynamics, CereGate, Cardionomic, Enspire DBS. AMN, JM, MAG, and CCM have patents and patent applications related to this work. AMN is a paid consultant and shareholder in Hologram Consultants. MAG's laboratory receives research support from Siemens Healthineers. MAG receives royalties from Siemens and GE. SS is a consultant for Boston Scientific, Zimmer Biomet, Koh Young, Sensoria Therapeutics, Varian Medical and Neuropace, as well as a co-founder of Motif Neurotech. NP is a consultant for Abbott, Boston Scientific, Second Sight Medical Products, and Sensoria Therapeutics.
(Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.)
References: Psychiatry Res Neuroimaging. 2017 Mar 30;261:72-74. (PMID: 28142056)
Biol Psychiatry. 2022 Aug 1;92(3):246-251. (PMID: 35063186)
Lancet Psychiatry. 2017 Nov;4(11):839-849. (PMID: 28988904)
Neurosurgery. 2021 Jul 15;89(2):E116-E121. (PMID: 33913499)
J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):886-896. (PMID: 29371415)
Mol Psychiatry. 2018 Apr;23(4):843-849. (PMID: 28397839)
Neuroimage. 2018 Sep;178:57-68. (PMID: 29758339)
Neuroimage. 2020 Nov 1;221:117180. (PMID: 32702488)
Neuroimage. 2021 Jan 15;225:117515. (PMID: 33137473)
Neuroimage. 2019 Jan 1;184:293-316. (PMID: 30179717)
Sci Data. 2018 Apr 17;5:180063. (PMID: 29664465)
Biol Psychiatry. 2009 Feb 15;65(4):267-75. (PMID: 18842257)
Hum Brain Mapp. 2012 Apr;33(4):958-68. (PMID: 21520343)
Biol Psychiatry. 2014 Dec 15;76(12):963-9. (PMID: 24832866)
Brain Stimul. 2022 May-Jun;15(3):554-565. (PMID: 35292403)
Biol Psychiatry. 2015 Aug 15;78(4):240-8. (PMID: 25726497)
Nat Rev Neurol. 2019 Mar;15(3):148-160. (PMID: 30683913)
Neuron. 2019 Dec 18;104(6):1056-1064.e3. (PMID: 31708306)
Brain Stimul. 2010 Apr;3(2):65-7. (PMID: 20607090)
Neuron. 2005 Mar 3;45(5):651-60. (PMID: 15748841)
Nat Commun. 2020 Jul 3;11(1):3364. (PMID: 32620886)
Nat Med. 2021 Feb;27(2):229-231. (PMID: 33462446)
Brain Stimul. 2023 Mar-Apr;16(2):411-414. (PMID: 36739892)
Neuroimage Clin. 2018;20:868-874. (PMID: 30282063)
Brain Stimul. 2021 Jul-Aug;14(4):1002-1004. (PMID: 34175247)
Neuromodulation. 2018 Feb;21(2):191-196. (PMID: 28653482)
Biol Psychiatry. 2018 Jul 1;84(1):28-37. (PMID: 29274805)
Neuroimage. 2018 May 15;172:263-277. (PMID: 29331449)
معلومات مُعتمدة: R01 MH106700 United States MH NIMH NIH HHS; R37 NS116079 United States NS NINDS NIH HHS; R01 MH127006 United States MH NIMH NIH HHS; R01 MH130597 United States MH NIMH NIH HHS; UH3 NS103549 United States NS NINDS NIH HHS; R01 NS105690 United States NS NINDS NIH HHS
فهرسة مساهمة: Keywords: DBS; Depression; HoloLens; Visualization; sEEG
سلسلة جزيئية: ClinicalTrials.gov NCT03437928
تواريخ الأحداث: Date Created: 20231222 Date Completed: 20231225 Latest Revision: 20240611
رمز التحديث: 20240611
مُعرف محوري في PubMed: PMC10784872
DOI: 10.1016/j.brs.2023.11.003
PMID: 38135359
قاعدة البيانات: MEDLINE
الوصف
تدمد:1876-4754
DOI:10.1016/j.brs.2023.11.003